240 related articles for article (PubMed ID: 24389959)
1. Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells.
Dong Y; Yin S; Jiang C; Luo X; Guo X; Zhao C; Fan L; Meng Y; Lu J; Song X; Zhang X; Chen N; Hu H
Autophagy; 2014 Feb; 10(2):296-310. PubMed ID: 24389959
[TBL] [Abstract][Full Text] [Related]
2. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J
Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802
[TBL] [Abstract][Full Text] [Related]
3. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.
Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J
Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980
[TBL] [Abstract][Full Text] [Related]
4. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces senescence-like terminal S-phase arrest in human hepatoma and breast cancer cells.
Yin S; Dong Y; Li J; Lü J; Hu H
Mol Carcinog; 2011 Aug; 50(8):592-600. PubMed ID: 21319227
[TBL] [Abstract][Full Text] [Related]
5. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J
Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750
[TBL] [Abstract][Full Text] [Related]
6. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.
Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH
Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.
Lee HJ; Seo NJ; Jeong SJ; Park Y; Jung DB; Koh W; Lee HJ; Lee EO; Ahn KS; Ahn KS; Lü J; Kim SH
Carcinogenesis; 2011 Jun; 32(6):804-11. PubMed ID: 21289371
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia K562 cells.
Kwon TR; Jeong SJ; Lee HJ; Lee HJ; Sohn EJ; Jung JH; Kim JH; Jung DB; Lu J; Kim SH
Biochem Biophys Res Commun; 2012 Aug; 424(3):530-7. PubMed ID: 22771329
[TBL] [Abstract][Full Text] [Related]
9. Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.
Hu H; Zhang J; Lee HJ; Kim SH; Lü J
Carcinogenesis; 2009 May; 30(5):818-23. PubMed ID: 19269999
[TBL] [Abstract][Full Text] [Related]
10. 1,2,3,4,6-Penta-O-galloyl-β-d-glucose suppresses colon cancer through induction of tumor suppressor.
Kawk SH; Kang YR; Kim YH
Bioorg Med Chem Lett; 2018 Jul; 28(12):2117-2123. PubMed ID: 29778287
[TBL] [Abstract][Full Text] [Related]
11. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
[TBL] [Abstract][Full Text] [Related]
12. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
Kant R; Yen CH; Hung JH; Lu CK; Tung CY; Chang PC; Chen YH; Tyan YC; Chen YA
Sci Rep; 2019 Feb; 9(1):1968. PubMed ID: 30760754
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor signaling activated by penta-O-galloyl-α-D: -glucopyranose induces p53 and apoptosis in cancer cells.
Cao Y; Evans SC; Soans E; Malki A; Liu Y; Liu Y; Chen X
Apoptosis; 2011 Sep; 16(9):902-13. PubMed ID: 21671008
[TBL] [Abstract][Full Text] [Related]
14. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
[TBL] [Abstract][Full Text] [Related]
15. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB
Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG).
Xiang Q; Tang J; Luo Q; Xue J; Tao Y; Jiang H; Tian J; Fan C
Biomed Pharmacother; 2019 Mar; 111():813-820. PubMed ID: 30616080
[TBL] [Abstract][Full Text] [Related]
17. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
[TBL] [Abstract][Full Text] [Related]
18. Penta-O-galloyl-β-D-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells.
Ryu HG; Jeong SJ; Kwon HY; Lee HJ; Lee EO; Lee MH; Choi SH; Ahn KS; Kim SH
Toxicol In Vitro; 2012 Mar; 26(2):206-14. PubMed ID: 22172427
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H
Kim JH; Im E; Lee J; Lee HJ; Sim DY; Park JE; Ahn CH; Kwon HH; Shim BS; Kim B; Kim SH
Cells; 2022 Apr; 11(8):. PubMed ID: 35456022
[TBL] [Abstract][Full Text] [Related]
20. Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes.
Liu X; Malki A; Cao Y; Li Y; Qian Y; Wang X; Chen X
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):308-16. PubMed ID: 25988880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
